LEN vs TKNO · rev $34.19B vs rev $37.7M
LEN (LEN) versus Alpha Teknova Inc (TKNO) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
Alpha Teknova Inc (TKNO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
Latest reported TKNO revenue for 2024-12-31 was $37.7M. Net income was -$26.7M. Revenue was up 2.9% from 2023-12-31 to 2024-12-31. TKNO currently screens at market cap $221.4M.
LEN currently screens at market cap $0. TKNO currently screens at market cap $221.4M.
Not investment advice. Open the LEN and TKNO stock pages for the full models.
Not investment advice.